Literature DB >> 35656091

High Intensity Interval Training: A Potential Method for Treating Sarcopenia.

Qian-Qi Liu1,2, Wen-Qing Xie1,3, Yu-Xuan Luo1,2, Yi-Dan Li1,2, Wei-Hong Huang4, Yu-Xiang Wu5, Yu-Sheng Li1,3.   

Abstract

Sarcopenia, an age-related disease characterized by loss of muscle strength and muscle mass, has attracted the attention of medical experts due to its severe morbidity, low living quality, high expenditure of health care, and mortality. Traditionally, persistent aerobic exercise (PAE) is considered as a valid way to attenuate muscular atrophy. However, nowadays, high intensity interval training (HIIT) has emerged as a more effective and time-efficient method to replace traditional exercise modes. HIIT displays comprehensive effects on exercise capacity and skeletal muscle metabolism, and it provides a time-out for the recovery of cardiopulmonary and muscular functions without causing severe adverse effects. Studies demonstrated that compared with PAE, HIIT showed similar or even higher effects in improving muscle strength, enhancing physical performances and increasing muscle mass of elder people. Therefore, HIIT might become a promising way to cope with the age-related loss of muscle mass and muscle function. However, it is worth mentioning that no study of HIIT was conducted directly on sarcopenia patients, which is attributed to the suspicious of safety and validity. In this review, we will assess the effects of different training parameters on muscle and sarcopenia, summarize previous papers which compared the effects of HIIT and PAE in improving muscle quality and function, and evaluate the potential of HIIT to replace the status of PAE in treating old people with muscle atrophy and low modality; and point out drawbacks of temporary experiments. Our aim is to discuss the feasibility of HIIT to treat sarcopenia and provide a reference for clinical scientists who want to utilize HIIT as a new way to cope with sarcopenia.
© 2022 Liu et al.

Entities:  

Keywords:  Sarcopenia; aging; high intensity interval training; persistent aerobic exercise

Mesh:

Year:  2022        PMID: 35656091      PMCID: PMC9152764          DOI: 10.2147/CIA.S366245

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   3.829


  174 in total

Review 1.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part I: aerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  High Intensity Interval Training Improves Physical Performance and Frailty in Aged Mice.

Authors:  Kenneth Ladd Seldeen; Ginger Lasky; Merced Marie Leiker; Manhui Pang; Kirkwood Ely Personius; Bruce Robert Troen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-14       Impact factor: 6.053

Review 3.  Effects of high-intensity interval training on cardiometabolic health: a systematic review and meta-analysis of intervention studies.

Authors:  Romeo B Batacan; Mitch J Duncan; Vincent J Dalbo; Patrick S Tucker; Andrew S Fenning
Journal:  Br J Sports Med       Date:  2016-10-20       Impact factor: 13.800

Review 4.  Practical Approaches to Prescribing Physical Activity and Monitoring Exercise Intensity.

Authors:  Jennifer L Reed; Andrew L Pipe
Journal:  Can J Cardiol       Date:  2015-12-29       Impact factor: 5.223

5.  Effect of low-intensity versus high-intensity resistance training on the functioning of the institutionalized frail elderly.

Authors:  Ulku K Sahin; Nuray Kirdi; Ergun Bozoglu; Aydin Meric; Galip Buyukturan; Ahmet Ozturk; Huseyin Doruk
Journal:  Int J Rehabil Res       Date:  2018-09       Impact factor: 1.479

Review 6.  High intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis.

Authors:  Mansueto Gomes Neto; André Rodrigues Durães; Lino Sergio Rocha Conceição; Micheli Bernardone Saquetto; Øyvind Ellingsen; Vitor Oliveira Carvalho
Journal:  Int J Cardiol       Date:  2018-03-05       Impact factor: 4.164

7.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.

Authors:  Liang-Kung Chen; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Ming-Yueh Chou; Katsuya Iijima; Hak Chul Jang; Lin Kang; Miji Kim; Sunyoung Kim; Taro Kojima; Masafumi Kuzuya; Jenny S W Lee; Sang Yoon Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Jae-Young Lim; Wee Shiong Lim; Li-Ning Peng; Ken Sugimoto; Tomoki Tanaka; Chang Won Won; Minoru Yamada; Teimei Zhang; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2020-02-04       Impact factor: 4.669

8.  Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors:  Ian Janssen; Steven B Heymsfield; Robert Ross
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

9.  Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium.

Authors:  Shalender Bhasin; Thomas G Travison; Todd M Manini; Sheena Patel; Karol M Pencina; Roger A Fielding; Jay M Magaziner; Anne B Newman; Douglas P Kiel; Cyrus Cooper; Jack M Guralnik; Jane A Cauley; Hidenori Arai; Brian C Clark; Francesco Landi; Laura A Schaap; Suzette L Pereira; Daniel Rooks; Jean Woo; Linda J Woodhouse; Ellen Binder; Todd Brown; Michelle Shardell; Quian-Li Xue; Ralph B DʼAgostino; Denise Orwig; Greg Gorsicki; Rosaly Correa-De-Araujo; Peggy M Cawthon
Journal:  J Am Geriatr Soc       Date:  2020-03-09       Impact factor: 5.562

10.  Effects of High Intensity Dynamic Resistance Exercise and Whey Protein Supplements on Osteosarcopenia in Older Men with Low Bone and Muscle Mass. Final Results of the Randomized Controlled FrOST Study.

Authors:  Wolfgang Kemmler; Matthias Kohl; Franz Jakob; Klaus Engelke; Simon von Stengel
Journal:  Nutrients       Date:  2020-08-05       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.